PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 45 filers reported holding PIERIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,006 | +80.1% | 6,730 | 0.0% | 0.00% | – |
| Q2 2023 | $1,114 | -93.6% | 6,730 | -62.0% | 0.00% | – |
| Q1 2023 | $17,304 | +30.7% | 17,730 | +39.3% | 0.00% | – |
| Q4 2022 | $13,239 | -87.7% | 12,730 | -64.4% | 0.00% | – |
| Q1 2022 | $108,000 | -33.7% | 35,776 | -17.0% | 0.00% | – |
| Q4 2021 | $163,000 | -55.0% | 43,120 | -38.4% | 0.00% | – |
| Q3 2021 | $362,000 | +36100.0% | 70,055 | +23251.7% | 0.00% | – |
| Q1 2021 | $1,000 | – | 300 | +435.7% | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 56 | -91.5% | 0.00% | – |
| Q1 2020 | $2,000 | 0.0% | 656 | +9.3% | 0.00% | – |
| Q4 2019 | $2,000 | -89.5% | 600 | -89.1% | 0.00% | – |
| Q3 2019 | $19,000 | +375.0% | 5,500 | +587.5% | 0.00% | – |
| Q2 2019 | $4,000 | – | 800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 5,628,585 | $5,853,728 | 5.06% |
| Aquilo Capital Management, LLC | 4,552,876 | $4,734,991 | 1.78% |
| BVF INC/IL | 5,080,320 | $5,283,533 | 0.22% |
| Soleus Capital Management, L.P. | 1,000,000 | $1,040,000 | 0.15% |
| Cutter & CO Brokerage, Inc. | 378,479 | $393,618 | 0.13% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,220,798 | $1,269,630 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 365,047 | $380 | 0.05% |
| Annandale Capital, LLC | 67,000 | $70 | 0.02% |
| WEALTH EFFECTS LLC | 21,700 | $22,568 | 0.01% |
| Sigma Planning Corp | 343,934 | $357,691 | 0.01% |